Adhesive properties and extracellular enzymatic activity of Staphylococcus aureus strains isolated from oral cavity

Microbial Pathogenesis

Volumn 73, Issue 1, 2014, Pages 7-12

  Meghrni, Abderrahmen ^a   Ben Nejma, Mouna ^a   Hentati, Hajer ^b   Mahjoub, Aouni ^a   Mastouri, Maha ^a,b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Biofilm; Hydrolytic enzymes; Orthodontic biomaterials; Staphylococcus aureus

Indexed keywords

BETA HEMOLYSIN; BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; CONGO RED; HEMOLYSIN; POLY(METHYL METHACRYLATE); PROTEINASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; HYDROLASE;

ADULT; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; DENTAL CARIES; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GEH GENE; HLB GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SSPA GENE; SSPB GENE; STAPHYLOCOCCUS AUREUS; TUNISIA; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOUTH; PHYSIOLOGY; SECRETION (PROCESS);

ADULT; BACTERIAL ADHESION; BACTERIOLOGICAL TECHNIQUES; BIOFILMS; FEMALE; HUMANS; HYDROLASES; MALE; MICROSCOPY, ATOMIC FORCE; MIDDLE AGED; MOUTH; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; TUNISIA;

EID: 84901478498     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.05.002     Document Type: Article

References (53)

1. Kroes I., Lepp P.W., Relman D.A. Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci 1999, 14:547-552.
2. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., Levanos V.A., et al. Bacterial diversity in human subgingival plaque. JBacteriol 2001, 183:3770-3783.
3. Buonavoglia A., Latronico F., Greco M.F., D'Abramo M., Marinaro M., Mangini F., et al. Methicillin-resistant staphylococci carriage in the oral cavity: a study conducted in Bari (Italy). Oral Dis 2010, 16:465-468.
4. Koreen L., Srinivas V., Ramaswamy E.A.Graviss, Naidich S., Musser J.M., Kreiswirth N. SpA typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to dentect genetic micro-and macrovariation. JClin Microbiol 2004, 42:792-799.
5. Cuesta A.I., Jewtuchowicz V., Brusca M.I., Nastri M.L., Rosa A.C. Prevalence ofStaphylococcus spp. and Candida spp. in the oral cavity and periodontalpockets of periodontal disease patients. Acta Odontol Latinoam 2010, 23:20-26.
6. Zaremba M.L., Stokowska W., Klimiuk A., Daniluk T., Rozkiewicz D., Cylwik-Rokicka D. Microorganisms in root carious lesions in adults. Adv Med Sci 2006, 51:237-240.
7. Sela M.N. Role of Treponema denticola in periodontal diseases. Oral Biol Med 2001, 12:399-413.
8. Coticchia J.M., Getnick G.S., Yun R.D., Arnold J.E. Age-site, and time-specific differences in pediatric deep neck abscesses. Arch Otolaryngol Head Neck Surg 2004, 130:201-207.
9. Ohara-Nemoto Y., Haraga H., Kimura S., Nemoto T.K. Occurrence of staphylococci in the oral cavities of healthy adults and nasal-oral trafficking of the bacteria. JMed Microbiol 2008, 57:95-99.
10. Valle J., Latasa C., Gil C., Arana A.T., Solano C., Penade J.R., et al. Bap, a biofilm matrix protein of Staphylococcus aureus prevents cellular internalization through binding to GP96 host receptor. PLoS Pathog 2012, 8:1-15.
11. Foster T.J., Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998, 6:484-488.
12. Furukawa S., Kuchma S.L., O'Toole G.A. Keeping their options open: acute versus persistent infections. JBacteriol 2006, 188:1211-1217.
13. Costerton J.W. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005, 437:7-11.
14. Heilmann C. Adhesion mechanisms of staphylococci. Adv Exp Med Biol 2011, 715:105-123.
15. Saïd-Salim B., Dunman P.M., McAleese F.M., Macapagal D., Murphy E., McNamara P.J., et al. Global regulation of Staphylococcus aureus genes by Rot. JBacteriol 2003, 185:610-619.
16. Projan S., Novick R. The molecular basis of pathogenicity. Staphylococci in human diseases 1997, 55-81. Churchill Livingstone, New York, N.Y. G. Archer, K. Crossley (Eds.).
17. Karlsson A., Arvidson S. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease Repressor sarA. Infect Immun 2002, 70:4239-4246.
18. Lowy F.D. Staphylococcus aureus infections. NEngl J Med 1998, 339:520-532.
19. Freeman D.J., Falkiner F.R., Keane C.T. New method for detecting slime production by coagulase negative staphylococci. JClin Pathol 1989, 42:872-874.
20. Touati A., Achour W., Abbassi M.S., Ben Hassen A. Detection of ica genes andslime production in a collection of Staphylococcus epidermidis strains fromcatheter-related infections in neutropenic patients. Pathol Biol 2007, 55:277-282.
21. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. JClin Microbiol 1985, 22:996-1006.
22. Mack D., Bartscht K., Fischer C., Rohde H., de Grahl C., Dobinsky S. Genetic and biochemical analysis of Staphylococcus epidermidis biofilm accumulation. Methods Enzymol 2001, 336:215-239.
23. Cheng L., Weir M.D., Xu H.H.K., Antonucci J.M., Kraigsley A.M., Lin N.J., et al. Antibacterial amorphous calcium phosphate nanocomposite with quaternary ammonium salt and silver nanoparticles. Dent Mater 2012, 2012(28):561-572.
24. Saising J., Dube L., Ziebandt A.K., Voravuthikunchai S.P., Nega M., Götz F. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2012, 56:5804-5810.
25. Braga P.C., Ricci D. Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime. Antimicrob Agents Chemother 1998, 42:18-22.
26. Williams K., Phillips K.D., Willis A.T. Asimple and sensitive method for detecting bacterial elastase production. Lett Appl Microb 1988, 7:173-176.
27. Quinn P.J., Carter M.E., Markey B.K., Carter G.R. The streptococci and related cocci. Clinical veterinary microbiology 1994, 127-136. P.J. Quinn, M.E. Carter, B. Markey, G.R. Carter (Eds.).
28. Irwin B.C., Mullally B., Ziada H., Allen E., Byrne P.J. Periodontics: 2. Risk factors and susceptibility in periodontitis. Dent Update 2007, 34:270-276.
29. Smith A.J., Robertson D., Tang M.K., Jackson M.S., MacKenzie D., Bagg J. Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data. Br Dent J 2003, 195:701-703.
30. Small H., Casey A.L., Elliott T.S., Rollason J., Hilton A.C., Ball S. The oral cavity - an overlooked site for MRSA screening and subsequent decolonisation therapy?. JInfect 2007, 55:378-383.
31. Zimmerli M., Widmer A.F., Dangel M., Filippi A., Frei R., Meyer J. Methicillin-resistant Staphylococcus aureus (MRSA) among dental patients: a problem for infection control in dentistry?. Clin Oral Investig 2009, 13:369-373.
32. Dahlen G., Linde A., Moller A.J., Ohman A. Aretrospective study of microbiologic samples from oral mucosal lesions. Oral Surg Oral Med Oral Pathol 1982, 53:250-255.
33. Ohman S.C., Osterberg T., Dahlen G., Landahl S. The prevalence of Staphylococcus aureus, Enterobacteriaceae species, and Candida species and their relation to oral mucosal lesions in a group of 79-year-olds in Goteborg. Acta Odontol Scand 1995, 53:49-54.
34. Gordon R.J., Lowy F.D. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46:350-359.
35. Barretti P., Montelli A.C., Batalha J.E., Caramori J.C., Cunha Mde L. The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients. BMC Infect Dis 2009, 9:212.
36. Kouidhi B., Zmantar T., Hentati H., Bakhrouf A. Cell surface hydrophobicity, biofilm formation, adhesives properties and molecular detection of adhesins genes in Staphylococcus aureus associated to dental caries. Microb Pathog 2010, 49:14-22.
37. Zmantar T., Kouidhi T., Miladi H., Mahdouani K., Bakhrouf A.A. Microtiter plate assay for Staphylococcus aureus biofilm quantification at various pH levels and hydrogen peroxide supplementatition. New Microbiol 2010, 33:137-145.
38. Lindsay J.A., Moore C.E., Day N.P., Peacock S.J., Witney A.A., Stabler R.A., et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. JBacteriol 2006, 188:669-676.
39. Grinholc M., Wegrzyn G., Kurlenda J. Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunol Med Microbiol 2007, 50:375-379.
40. Jain A., Agarwal A. Biofilm production, a marker of pathogenic potential ofcolonizing and commensal staphylococci. JMicrobiol Methods 2009, 76:88-92.
41. Mathur T., Singhal S., Khan S., Upadhyay D.J., Fatma T., Rattan A. Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol 2006, 24:25-29.
42. Rode T.M., Langsrud S., Holck A., Moretro T. Different patterns of biofilm formation in Staphylococcus aureus under food-related stress conditions. Int J Food Microbiol 2007, 116:372-383.
43. Fueyo J.M., Mendoza M.C., Martín M.C. Enterotoxins and toxic shock syndrome toxin in Staphylococcus aureus recovered from human nasal carriers and manually handled foods: epidemiological and genetic findings. Microbes Infect 2005, 7:187-194.
44. Lakshmi H.P., Prasad U.V., Yeswanth S., Swarupa V., Prasad O.H., Narasu M.L., et al. Molecular characterization of α-amylase from Staphylococcus aureus. Bioinformation 2013, 9:281-285.
45. Dingues M.M., Orwin P.M., Schlievert M. Exotoxins of Staphylococcus aureus. Clin Microb Rev 2000, 13:16-34.
46. Peacock S.J., Howe P.A., Day N.P., Crook D.W., Winearls C.G., Berendt A.R. Outcome following staphylococcal peritonitis. Perit Dial Int 2000, 20:215-219.
47. Saising J., Singdam S., Ongsakul M., Voravuthikunchai S.P. Lipase, protease, and biofilm as the major virulence factors in staphylococci isolated from acne lesions. Biosci Trends 2012, 6:160-164.
48. Miedzobrodzki J., Kaszycki P., Bialecka A., Kasprowicz A. Proteolytic activity of Staphylococcus aureus strains isolated from the colonized skin of patients with acutephase atopic dermatitis. Eur J Clin Microbiol Infect Dis 2002, 21:269-276.
49. Wu P.Z., Zhu H., Thakur A., Willcox M.D. Comparison of potential pathogenic traits of staphylococci that may contribute to corneal ulceration and inflammation. Aust N Z J Ophthalmol 1999, 27:234-236.
50. Sudagidan M., Aydin A. Virulence properties of methicillin-susceptible Staphylococcus aureus food isolates encoding Panton-Valentine Leukocidin gene. Int J Food Microbiol 2010, 138:287-291.
51. Dubin G. Extracellular proteases of Staphylococcus spp. Biol Chem 2002, 383:1075-1086.
52. Huseby M., Shi K., Brown C.K., Digre J., Mengistu F., Seo K.S., et al. Structure and biological activities of beta toxin from Staphylococcus aureus. JBacteriol 2007, 189:8719-8726.
53. O'Callaghan R.J., Callegan M.C., Moreau J.M., Green L.C., Foster T.J., Hartford O.M., et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal. Infect Infect Immun 1997, 65:1571-1578.